{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:08Z","timestamp":1786981508168,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-023-09061-5","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T12:15:42Z","timestamp":1706184942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The association of ABCB1 gene polymorphism with clinical response to carbamazepine monotherapy in patients with epilepsy"],"prefix":"10.1007","volume":"51","author":[{"given":"Haroon Ur","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ijaz Khan","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Imran","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujeeb Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-9557","authenticated-orcid":false,"given":"Muhammad Khalid","family":"Tipu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"9061_CR1","volume-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","author":"P Kwan","year":"2010","unstructured":"Kwan P et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Wiley, Hoboken"},{"issue":"9971","key":"9061_CR2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"SL Mosh\u00e9","year":"2015","unstructured":"Mosh\u00e9 SL et al (2015) Epilepsy: new advances. Lancet 385(9971):884\u2013898","journal-title":"Lancet"},{"issue":"4","key":"9061_CR3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55(4):475\u2013482","journal-title":"Epilepsia"},{"key":"9061_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cotox.2018.12.004","volume":"11","author":"A Heinrich","year":"2018","unstructured":"Heinrich A, Zhong XB, Rasmussen TP (2018) Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the ABCB1 gene: implications for drug-resistant epilepsy. Curr Opinion Toxicol 11:35\u201342","journal-title":"Curr Opinion Toxicol"},{"issue":"10","key":"9061_CR5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.addr.2011.10.003","volume":"64","author":"CJ Landmark","year":"2012","unstructured":"Landmark CJ, Johannessen SI, Tomson T (2012) Host factors affecting antiepileptic drug delivery\u2014pharmacokinetic variability. Adv Drug Deliv Rev 64(10):896\u2013910","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9061_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1167.2008.01716.x","volume":"50","author":"W L\u00f6scher","year":"2009","unstructured":"L\u00f6scher W et al (2009) The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 50(1):1\u201323","journal-title":"Epilepsia"},{"issue":"12","key":"9061_CR7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","volume":"42","author":"SM Dombrowski","year":"2001","unstructured":"Dombrowski SM et al (2001) Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42(12):1501\u20131506","journal-title":"Epilepsia"},{"issue":"1","key":"9061_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","volume":"36","author":"DM Tishler","year":"1995","unstructured":"Tishler DM et al (1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36(1):1\u20136","journal-title":"Epilepsia"},{"key":"9061_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","volume":"48","author":"A Lazarowski","year":"2007","unstructured":"Lazarowski A et al (2007) ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. Epilepsia 48:140\u2013149","journal-title":"Epilepsia"},{"key":"9061_CR10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14622416.6.4.411","volume":"6","author":"CC Hung","year":"2005","unstructured":"Hung CC et al (2005) Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 6:411","journal-title":"Pharmacogenomics"},{"issue":"10","key":"9061_CR11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1517\/14656566.8.10.1441","volume":"8","author":"SK Tate","year":"2007","unstructured":"Tate SK, Sisodiya SM (2007) Multidrug resistance in epilepsy: a pharmacogenomic update. Expert Opin Pharmacother 8(10):1441\u20131449","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"9061_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12993-016-0106-z","volume":"12","author":"M Stasio\u0142ek","year":"2016","unstructured":"Stasio\u0142ek M et al (2016) Association between C3435T polymorphism of MDR1 gene and the incidence of drug-resistant epilepsy in the population of Polish children. Behav Brain Funct 12(1):1\u20136","journal-title":"Behav Brain Funct"},{"issue":"2","key":"9061_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.braindev.2013.01.016","volume":"36","author":"S Saygi","year":"2014","unstructured":"Saygi S et al (2014) Multidrug resistance 1 (MDR1) 3435C\/T genotyping in childhood drug-resistant epilepsy. Brain Develop 36(2):137\u2013142","journal-title":"Brain Develop"},{"issue":"11","key":"9061_CR14","doi-asserted-by":"crossref","first-page":"e0142408","DOI":"10.1371\/journal.pone.0142408","volume":"10","author":"A Daci","year":"2015","unstructured":"Daci A et al (2015) Polymorphic variants of SCN1A and EPHX1 influence plasma carbamazepine concentration, metabolism and pharmacoresistance in a population of Kosovar Albanian epileptic patients. PLoS ONE 10(11):e0142408","journal-title":"PLoS ONE"},{"key":"9061_CR15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/14622416.7.4.551","volume":"4","author":"T Seo","year":"2006","unstructured":"Seo T et al (2006) ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 4:551","journal-title":"Pharmacogenomics"},{"issue":"10","key":"9061_CR16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","volume":"42","author":"P Kwan","year":"2001","unstructured":"Kwan P, Brodie MJ (2001) Effectiveness of first antiepileptic drug. Epilepsia 42(10):1255\u20131260","journal-title":"Epilepsia"},{"issue":"8","key":"9061_CR17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","volume":"55","author":"C Luna-Tort\u00f3s","year":"2008","unstructured":"Luna-Tort\u00f3s C, Fedrowitz M, L\u00f6scher W (2008) Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology 55(8):1364\u20131375","journal-title":"Neuropharmacology"},{"key":"9061_CR18","volume-title":"Methods in observational epidemiology","author":"JL Kelsey","year":"1996","unstructured":"Kelsey JL et al (1996) Methods in observational epidemiology. Oxford University Press, Oxford"},{"key":"9061_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pharmthera.2005.04.003","volume":"107","author":"M Yano","year":"2005","unstructured":"Yano M (2005) A simple salting out procedure for extracting DNA from human nucleated cells. Pharmacol Ther 107:377\u2013391","journal-title":"Pharmacol Ther"},{"issue":"4","key":"9061_CR20","first-page":"2159","volume":"10","author":"E Ezzeldin","year":"2013","unstructured":"Ezzeldin E, Shahat AA, Basudan OA (2013) Development and validation of an HPLC method for the determination of carbamazepine in human plasma. Life Sci J 10(4):2159\u20132163","journal-title":"Life Sci J"},{"issue":"2","key":"9061_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","volume":"15","author":"Y Yong","year":"2005","unstructured":"Yong Y, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction and genetic association at polymorphism loci. Cell Res 15(2):97","journal-title":"Cell Res"},{"issue":"5","key":"9061_CR22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1528-1167.2005.46304.x","volume":"46","author":"GJ Sills","year":"2005","unstructured":"Sills GJ et al (2005) Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 46(5):643\u2013647","journal-title":"Epilepsia"},{"issue":"2","key":"9061_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2006.10.004","volume":"73","author":"A Shahwan","year":"2007","unstructured":"Shahwan A et al (2007) The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res 73(2):192\u2013198","journal-title":"Epilepsy Res"},{"issue":"6","key":"9061_CR24","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/01.WNL.0000141021.42763.F6","volume":"63","author":"F Zimprich","year":"2004","unstructured":"Zimprich F et al (2004) Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 63(6):1087\u20131089","journal-title":"Neurology"},{"issue":"1","key":"9061_CR25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","volume":"11","author":"P Kwan","year":"2007","unstructured":"Kwan P et al (2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 11(1):112\u2013117","journal-title":"Epilepsy Behav"},{"issue":"1","key":"9061_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yebeh.2011.02.015","volume":"21","author":"H Meng","year":"2011","unstructured":"Meng H et al (2011) Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Behav 21(1):27\u201330","journal-title":"Epilepsy Behav"},{"key":"9061_CR27","doi-asserted-by":"crossref","first-page":"106785","DOI":"10.1016\/j.eplepsyres.2021.106785","volume":"177","author":"YX Fan","year":"2021","unstructured":"Fan YX et al (2021) Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: a meta-analysis. Epilepsy Res 177:106785","journal-title":"Epilepsy Res"},{"issue":"9","key":"9061_CR28","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/biomedicines11092505","volume":"11","author":"R Magadmi","year":"2023","unstructured":"Magadmi R et al (2023) Polymorphisms in the drug transporter gene ABCB1 are associated with drug response in Saudi epileptic pediatric patients. Biomedicines 11(9):2505","journal-title":"Biomedicines"},{"issue":"6","key":"9061_CR29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/FTD.0000000000000805","volume":"42","author":"T Zhao","year":"2020","unstructured":"Zhao T et al (2020) Impact of ABCB1 polymorphism on levetiracetam serum concentrations in epileptic uygur children in China. Ther Drug Monit 42(6):886","journal-title":"Ther Drug Monit"},{"key":"9061_CR30","first-page":"191","volume":"8","author":"Z Sterjev","year":"2012","unstructured":"Sterjev Z et al (2012) The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy. Neuropsychiatr Dis Treat 8:191\u2013196","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"9061_CR31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","volume":"46","author":"D Schmidt","year":"2005","unstructured":"Schmidt D, L\u00f6scher W (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46(6):858\u2013877","journal-title":"Epilepsia"},{"issue":"1","key":"9061_CR32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","volume":"129","author":"S Remy","year":"2006","unstructured":"Remy S, Beck H (2006) Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129(1):18\u201335","journal-title":"Brain"},{"issue":"8","key":"9061_CR33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","volume":"6","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H (2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6(8):591\u2013602","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"9061_CR34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/FTD.0b013e318067ce90","volume":"29","author":"A-HIM Ebid","year":"2007","unstructured":"Ebid A-HIM, Ahmed MM, Mohammed SA (2007) Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. Ther Drug Monit 29(3):305\u2013312","journal-title":"Ther Drug Monit"},{"issue":"12","key":"9061_CR35","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0883073810368997","volume":"25","author":"A Alpman","year":"2010","unstructured":"Alpman A et al (2010) Multidrug resistance 1 (MDR1) gene polymorphisms in childhood drug-resistant epilepsy. J Child Neurol 25(12):1485\u20131490","journal-title":"J Child Neurol"},{"issue":"5","key":"9061_CR36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2006.02.015","volume":"15","author":"DW Kim","year":"2006","unstructured":"Kim DW et al (2006) Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure 15(5):344\u2013347","journal-title":"Seizure"},{"issue":"6","key":"9061_CR37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/01.WNL.0000137051.33486.C7","volume":"63","author":"N Tan","year":"2004","unstructured":"Tan N et al (2004) Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63(6):1090\u20131092","journal-title":"Neurology"},{"issue":"8","key":"9061_CR38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/00207454.2017.1412964","volume":"128","author":"M Ajmi","year":"2018","unstructured":"Ajmi M et al (2018) Association between ABCB1 polymorphisms and response to first-generation antiepileptic drugs in a Tunisian epileptic population. Int J Neurosci 128(8):705\u2013714","journal-title":"Int J Neurosci"},{"key":"9061_CR39","first-page":"140","volume":"46","author":"T Zhao","year":"2023","unstructured":"Zhao T et al (2023) ABCB1 gene polymorphisms are closely associated with drug-resistant epilepsy: evidence based on 377 subjects in Chinese pediatric patients. Clin Neuropharmacol 46:140","journal-title":"Clin Neuropharmacol"},{"issue":"15","key":"9061_CR40","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","volume":"348","author":"A Siddiqui","year":"2003","unstructured":"Siddiqui A et al (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348(15):1442\u20131448","journal-title":"N Engl J Med"},{"issue":"7","key":"9061_CR41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1101\/gr.1965304","volume":"14","author":"N Soranzo","year":"2004","unstructured":"Soranzo N et al (2004) Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res 14(7):1333\u20131344","journal-title":"Genome Res"},{"issue":"1","key":"9061_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-017-0801-x","volume":"17","author":"M Chouchi","year":"2017","unstructured":"Chouchi M et al (2017) Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis. BMC Neurol 17(1):1\u201314","journal-title":"BMC Neurol"},{"issue":"1","key":"9061_CR43","first-page":"3","volume":"7","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W (2005) Mechanisms of drug resistance. Epileptic Disord 7(1):3\u20139","journal-title":"Epileptic Disord"},{"issue":"2","key":"9061_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.seizure.2009.12.004","volume":"19","author":"MB S\u00e1nchez","year":"2010","unstructured":"S\u00e1nchez MB et al (2010) Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure 19(2):93\u2013101","journal-title":"Seizure"},{"issue":"5","key":"9061_CR45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.seizure.2011.01.008","volume":"20","author":"BS Haerian","year":"2011","unstructured":"Haerian BS et al (2011) Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. Seizure 20(5):387\u2013394","journal-title":"Seizure"},{"key":"9061_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1343650","volume":"2019","author":"M Chouchi","year":"2019","unstructured":"Chouchi M et al (2019) ABCB1 polymorphisms and drug-resistant epilepsy in a Tunisian population. Dis Mark 2019:1\u201316","journal-title":"Dis Mark"},{"issue":"3","key":"9061_CR47","doi-asserted-by":"crossref","first-page":"e0122043","DOI":"10.1371\/journal.pone.0122043","volume":"10","author":"H Li","year":"2015","unstructured":"Li H et al (2015) The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies. PLoS ONE 10(3):e0122043","journal-title":"PLoS ONE"},{"issue":"4","key":"9061_CR48","first-page":"469","volume":"23","author":"AT Butila","year":"2015","unstructured":"Butila AT et al (2015) ABCB1 gene polymorphisms is not associated with drug-resistant epilepsy in Romanian children. Rev Romana Med Lab 23(4):469\u2013482","journal-title":"Rev Romana Med Lab"},{"key":"9061_CR49","doi-asserted-by":"crossref","first-page":"106814","DOI":"10.1016\/j.eplepsyres.2021.106814","volume":"178","author":"H Maqbool","year":"2021","unstructured":"Maqbool H et al (2021) Polymorphism in drug transporter gene ABCB1 is associated with drug resistance in Pakistani epilepsy patients. Epilepsy Res 178:106814","journal-title":"Epilepsy Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-09061-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T15:36:12Z","timestamp":1738683372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-09061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9061"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-09061-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to protocol number BEC-FBS-QAU2021-342, the study was approved by the Quaid-i-Azam University Islamabad's bioethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Clear verbal and written information about the study was provided to participants\u2019 parent\/guardian in their native language. The recruited patients gave their informed consent voluntarily.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"191"}}